(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States...
Stats | |
---|---|
今日成交量 | 7 650.00 |
平均成交量 | 13 398.00 |
市值 | 278.95M |
EPS | $0 ( 2024-03-25 ) |
下一个收益日期 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -62.21 |
ATR14 | $0.204 (0.63%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Waldrop Jacob A. | Buy | 3 101 | Common Stock |
2024-04-15 | Waldrop Jacob A. | Buy | 0 | |
2024-03-07 | Fleming Zachary B. | Buy | 12 693 | Common Stock |
2024-03-07 | Mcneil Michael D. | Buy | 4 650 | Common Stock |
2024-03-01 | Fleming Zachary B. | Sell | 926 | Common Stock |
INSIDER POWER |
---|
63.62 |
Last 96 transactions |
Buy: 222 356 | Sell: 29 380 |
Sanara MedTech Inc. 财务报表
Annual | 2023 |
营收: | $64.99M |
毛利润: | $53.46M (82.26 %) |
EPS: | $-0.520 |
FY | 2023 |
营收: | $64.99M |
毛利润: | $53.46M (82.26 %) |
EPS: | $-0.520 |
FY | 2022 |
营收: | $45.84M |
毛利润: | $39.48M (86.12 %) |
EPS: | $-1.020 |
FY | 2021 |
营收: | $24.14M |
毛利润: | $21.24M (87.95 %) |
EPS: | $-1.381 |
Financial Reports:
No articles found.
Sanara MedTech Inc.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。